Michela Rosso

Michela Rosso

Auto-generated profile, based on publicly available information

Michela Rosso

Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2017 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
AEAlberto J. Espay
Alberto J. Espay
GPGustavo A. Da Prat
Gustavo A. Da Prat
ADAlok K. Dwivedi
Alok K. Dwivedi
FRFederico Rodriguez‐Porcel
Federico Rodriguez‐Porcel
JVJennifer E. Vaughan
Jennifer E. Vaughan
ALAnthony E. Lang
Anthony E. Lang

26 December 2017 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
AMAristide Merola
Aristide Merola
ARAlberto Romagnolo
Alberto Romagnolo
MRMichela Rosso
Michela Rosso
RSRitika Suri
Ritika Suri
ZBZoe Berndt
Zoe Berndt
AEAlberto J. Espay
Alberto J. Espay

1 December 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
AMAristide Merola
Aristide Merola
ARAlberto Romagnolo
Alberto Romagnolo
MRMichela Rosso
Michela Rosso
JLJosé Ricardo Lopez-Castellanos
José Ricardo Lopez-Castellanos
BWBenjamin D. Wissel
Benjamin D. Wissel
AEAlberto J. Espay
Alberto J. Espay

29 May 2019 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
APAndrea Pilotto
Andrea Pilotto
ARAlberto Romagnolo
Alberto Romagnolo
JTJasmine A Tuazon
Jasmine A Tuazon
JVJoaquin A. Vizcarra
Joaquin A. Vizcarra
Luca MarsiliLuca Marsili
Luca Marsili
AMAristide Merola
Aristide Merola
Objective Review the effect of orthostatic hypotension (OH) and rapid-eye-movement sleep behavioural disorder (RBD) on survival, cognitive impairment and postural stability, and discuss pathogenic mechanisms involved in the association of these two common non-motor features with relevant clinical outcomes in α-synucleinopathies. Methods We searched PubMed (January 2007–February 2019) for human studies of OH and RBD evaluating cognitive impairment, postural instability, and survival in Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) and pure autonomic failure (PAF). Included studies were analysed for design, key results and limitations as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results OH and RBD showed a positive association with cognitive impairment in PD and DLB, conflicting association in PAF, and no association in MSA. OH was correlated with incident falls and postural instability in PD and DLB but not in MSA. The association between RBD and postural instability was inconclusive; positive in five studies, negative in seven. OH, but not RBD, correlated with reduced survival in PD, DLB and MSA. The combination of OH and RBD was associated with cognitive impairment and more rapid progression of postural instability. Conclusions OH and RBD yielded individual and combined negative effects on disability in α-synucleinopathies, reflecting a ‘malignant’ phenotype of PD with early cognitive impairment and postural instability. Underlying mechanisms may include involvement of selected brainstem cholinergic and noradrenergic nuclei.

1 August 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
AMAristide Merola
Aristide Merola
AEAlberto J. Espay
Alberto J. Espay
ARAlberto Romagnolo
Alberto Romagnolo
ABAndrea Bernardini
Andrea Bernardini
LRLaura Rizzi
Laura Rizzi
LLLeonardo Lopiano
Leonardo Lopiano

8 May 2017 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
AMAristide Merola
Aristide Merola
MRMichela Rosso
Michela Rosso
ARAlberto Romagnolo
Alberto Romagnolo
Cristoforo ComiCristoforo Comi
Cristoforo Comi
Alfonso FasanoAlfonso Fasano
Alfonso Fasano
AEAlberto J. Espay
Alberto J. Espay